JP2019533644A5 - - Google Patents

Download PDF

Info

Publication number
JP2019533644A5
JP2019533644A5 JP2019514312A JP2019514312A JP2019533644A5 JP 2019533644 A5 JP2019533644 A5 JP 2019533644A5 JP 2019514312 A JP2019514312 A JP 2019514312A JP 2019514312 A JP2019514312 A JP 2019514312A JP 2019533644 A5 JP2019533644 A5 JP 2019533644A5
Authority
JP
Japan
Prior art keywords
composition
combination
permeation enhancer
permeation
sol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019514312A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019533644A (ja
JP7277360B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/051577 external-priority patent/WO2018053140A1/en
Publication of JP2019533644A publication Critical patent/JP2019533644A/ja
Publication of JP2019533644A5 publication Critical patent/JP2019533644A5/ja
Application granted granted Critical
Publication of JP7277360B2 publication Critical patent/JP7277360B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019514312A 2016-09-14 2017-09-14 薬物送達のための透過促進剤を有する組成物 Active JP7277360B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662394716P 2016-09-14 2016-09-14
US62/394,716 2016-09-14
PCT/US2017/051577 WO2018053140A1 (en) 2016-09-14 2017-09-14 Compositions with permeation enhancers for drug delivery

Publications (3)

Publication Number Publication Date
JP2019533644A JP2019533644A (ja) 2019-11-21
JP2019533644A5 true JP2019533644A5 (enExample) 2020-11-05
JP7277360B2 JP7277360B2 (ja) 2023-05-18

Family

ID=61619716

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019514312A Active JP7277360B2 (ja) 2016-09-14 2017-09-14 薬物送達のための透過促進剤を有する組成物

Country Status (8)

Country Link
US (1) US20200138710A1 (enExample)
EP (1) EP3512501A4 (enExample)
JP (1) JP7277360B2 (enExample)
KR (1) KR20190053215A (enExample)
CN (2) CN109937033A (enExample)
AU (1) AU2017326347B2 (enExample)
CA (1) CA3036696A1 (enExample)
WO (1) WO2018053140A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1252531A1 (zh) 2015-08-05 2019-05-31 Children's Medical Center Corporation 用於药物递送的具有渗透增强剂的组合物
US20230270749A1 (en) * 2020-08-03 2023-08-31 Children's Medical Center Corporation Thermo-sensitive permeation enhancing formulations for drug delivery
GB202100945D0 (en) * 2021-01-25 2021-03-10 Brightcure Ltd A composition useful for treating bacterial infections
DE202021106639U1 (de) 2021-10-08 2023-01-10 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mit beschränkter Haftung Neue Therapiekonzepte für die Behandlung von Otitis
CN117618338A (zh) * 2022-08-16 2024-03-01 海南普利制药股份有限公司 一种稳定的奥利万星药物水溶液及其制备方法
CN118518439B (zh) * 2023-02-17 2025-09-16 清华大学 离子液体制剂和组织处理方法及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0725628T3 (da) * 1994-08-30 2001-12-27 Alcon Lab Inc Termisk geldannende lægemiddelindgivelsesvehikler indeholdende celluloseethere
EP1109563A4 (en) * 1998-08-04 2009-07-22 Madash Llp AT THE END MODIFIED HYDROGELE WITH TEMPERATURE DEPENDENT FEATURES
EP1609468A3 (en) * 2000-11-22 2006-01-25 Rxkinetix, Inc. A composition on the basis of a sulfur-containing antioxidant and its use for the manufacture of a medicament for treating mucositis
US7220431B2 (en) * 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
US9056061B2 (en) * 2005-09-23 2015-06-16 Alza Corporation Transdermal nicotine salt delivery system
WO2009142719A2 (en) * 2008-05-19 2009-11-26 Massachusetts Institute Of Technology Tympanic membrane permeating ear drops and uses thereof
CA2732686C (en) * 2008-12-22 2017-10-03 Otonomy, Inc. Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders
HK1252531A1 (zh) * 2015-08-05 2019-05-31 Children's Medical Center Corporation 用於药物递送的具有渗透增强剂的组合物

Similar Documents

Publication Publication Date Title
JP2019533644A5 (enExample)
JP2018522905A5 (enExample)
RU2495662C2 (ru) Антимикробные композиции с контролируемым высвобождением для лечения ушных заболеваний
JP2023523155A5 (enExample)
JP2022031534A (ja) 新規な鎮痛組成物
JP2008533048A (ja) 耳の感染症の治療方法
US12201622B2 (en) Continuous delivery of lenalidomide and other immunomodulatory agents
BRPI0608690A2 (pt) uso de uma composição antimicrobiana
EP3446692A1 (en) Methods of preserving injectable pharmaceutical compositions comprising a cyclodextrin and a hydrophobic drug
JP6224115B2 (ja) 騒音嫌悪を軽減する獣医学的方法
CN101663022A (zh) 局部药物制剂
JP2011173928A5 (enExample)
CN113853196B (zh) 长效可注射调配物和其用途
US20250302966A1 (en) Fulvestrant formulations
BR122021011439B1 (pt) Formulação em gel de bisfosfocina e usos da mesma
JP2010195823A (ja) 小動物用の注射可能な獣医用組成物
US20140348959A1 (en) Formulations and Methods for Treating Ear Conditions
US9511077B2 (en) Medical devices and methods comprising an anabolic agent for wound healing
PT1811995E (pt) Composição veterinária transmucosa compreendendo detomidina
EP2836199B1 (en) Fulvestrant formulations
JP6903411B2 (ja) 外用組成物
US20200330436A1 (en) Compositions and Methods for Treatment and Prevention of Pyrexia in Horses
TWI649097B (zh) 乙醯胺酚之可注射製劑
CN101677943A (zh) 使用苯甲醇的多剂量浓缩艾司洛尔
JP2005089345A (ja) 虫刺され治療薬